Related references
Note: Only part of the references are listed.Ferumoxytol as an Intravenous Iron Replacement Therapy in Hemodialysis Patients
Robert Provenzano et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Iron Indices in Chronic Kidney Disease in the National Health and Nutritional Examination Survey 1988-2004
Steven Fishbane et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Physicochemical properties of ferumoxytol, a new intravenous iron preparation
V. S. Balakrishnan et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
Edward A. Neuwelt et al.
KIDNEY INTERNATIONAL (2009)
Safety of Ferumoxytol in Patients With Anemia and CKD
Ajay Singh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: Systematic Review and Meta-analysis
Benaya Rozen-Zvi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Ferumoxytol as a New, Safer, Easier-to-Ad minister Intravenous Iron: Yes or No?
Michael Auerbach
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Ferumoxytol for Treating Iron Deficiency Anemia in CKD
Bruce S. Spinowitz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease
M. Auerbach et al.
KIDNEY INTERNATIONAL (2008)
Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
Dorine W. Swinkels et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
New insights into nephrogenic systemic fibrosis
Sundararaman Swaminathan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis
Amy Barton Pai et al.
PHARMACOTHERAPY (2007)
Update on adverse drug events associated with parenteral iron
GM Chertow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD
DB Van Wyck et al.
KIDNEY INTERNATIONAL (2005)
The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients
BS Spinowitz et al.
KIDNEY INTERNATIONAL (2005)
Pharmacokinetic study of ferumoxytol: A new iron replacement therapy in normal subjects and hemodialysis patients
R Landry et al.
AMERICAN JOURNAL OF NEPHROLOGY (2005)
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
J Himmelfarb et al.
KIDNEY INTERNATIONAL (2002)
Share Paper
